172 related articles for article (PubMed ID: 34543448)
1. Lymphocyte Profile and Immune Checkpoint Expression in Drug-Induced Liver Injury: An Immunophenotyping Study.
Cueto-Sanchez A; Niu H; Del Campo-Herrera E; Robles-Díaz M; Sanabria-Cabrera J; Ortega-Alonso A; Garcia-Cortes M; Gonzalez-Grande R; Jimenez-Perez M; Ruiz-Cabello F; Andrade RJ; Lucena MI; Stephens C
Clin Pharmacol Ther; 2021 Dec; 110(6):1604-1612. PubMed ID: 34543448
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis.
Foureau DM; Walling TL; Maddukuri V; Anderson W; Culbreath K; Kleiner DE; Ahrens WA; Jacobs C; Watkins PB; Fontana RJ; Chalasani N; Talwalkar J; Lee WM; Stolz A; Serrano J; Bonkovsky HL
Clin Exp Immunol; 2015 Apr; 180(1):40-51. PubMed ID: 25418487
[TBL] [Abstract][Full Text] [Related]
3. Adaptive immunity in autoimmune hepatitis.
Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
Dig Dis; 2010; 28(1):63-9. PubMed ID: 20460892
[TBL] [Abstract][Full Text] [Related]
4. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis.
Weber S; Benesic A; Rotter I; Gerbes AL
Liver Int; 2019 Oct; 39(10):1906-1917. PubMed ID: 31319011
[TBL] [Abstract][Full Text] [Related]
5. Aetiopathogenesis of autoimmune hepatitis.
Vergani D; Mieli-Vergani G
World J Gastroenterol; 2008 Jun; 14(21):3306-12. PubMed ID: 18528928
[TBL] [Abstract][Full Text] [Related]
6. [Drug-induced autoimmune-like liver injury].
Weber S
Inn Med (Heidelb); 2024 Apr; 65(4):334-339. PubMed ID: 38374310
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 and Fas expression in peripheral blood leukocytes of patients with alcoholic and autoimmune liver disorders.
Zwolak A; Surdacka A; Daniluk J
Hum Exp Toxicol; 2016 Aug; 35(8):799-807. PubMed ID: 26429926
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune Hepatitis and Autoimmune Hepatitis Overlap With Sclerosing Cholangitis: Immunophenotype Markers in Children and Adolescents.
Ferri PM; Simões E Silva AC; Torres KCL; Silva SLC; Aquino DJQ; Ferreira MLM; Fagundes EDT; Miranda DM; Ferreira AR
J Pediatr Gastroenterol Nutr; 2018 Feb; 66(2):204-211. PubMed ID: 29045346
[TBL] [Abstract][Full Text] [Related]
9. Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis.
Aarslev K; Dige A; Greisen SR; Kreutzfeldt M; Jessen N; Vilstrup H; Deleuran B; Grønbæk H
Scand J Gastroenterol; 2017 Jan; 52(1):93-99. PubMed ID: 27604386
[TBL] [Abstract][Full Text] [Related]
10. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
[No Abstract] [Full Text] [Related]
11. Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response.
Whritenour J; Ko M; Zong Q; Wang J; Tartaro K; Schneider P; Olson E; Van Volkenburg M; Serrano J; Hayashi P; Fontana R; Chalasani N; Bonkovsky HL
J Immunotoxicol; 2017 Dec; 14(1):31-38. PubMed ID: 28121193
[TBL] [Abstract][Full Text] [Related]
12. Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.
de Boer YS; Kosinski AS; Urban TJ; Zhao Z; Long N; Chalasani N; Kleiner DE; Hoofnagle JH;
Clin Gastroenterol Hepatol; 2017 Jan; 15(1):103-112.e2. PubMed ID: 27311619
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease is a potential risk factor for liver injury caused by immune checkpoint inhibitor.
Sawada K; Hayashi H; Nakajima S; Hasebe T; Fujiya M; Okumura T
J Gastroenterol Hepatol; 2020 Jun; 35(6):1042-1048. PubMed ID: 31752049
[TBL] [Abstract][Full Text] [Related]
14. Pathology of immune-mediated liver injury.
Dienes HP; Drebber U
Dig Dis; 2010; 28(1):57-62. PubMed ID: 20460891
[TBL] [Abstract][Full Text] [Related]
15. "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis.
Sebode M; Schulz L; Lohse AW
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28895915
[TBL] [Abstract][Full Text] [Related]
16. Activation and transcriptional profile of monocytes and CD8
Gudd CLC; Au L; Triantafyllou E; Shum B; Liu T; Nathwani R; Kumar N; Mukherjee S; Dhar A; Woollard KJ; Yone Y; Pinato DJ; Thursz MR; Goldin RD; Gore ME; Larkin J; Khamri W; Antoniades CG; Turajlic S; Possamai LA
J Hepatol; 2021 Jul; 75(1):177-189. PubMed ID: 33631227
[TBL] [Abstract][Full Text] [Related]
17. Increase in CD95 (Fas/APO-1)-positive CD4+ and CD8+ T cells in peripheral blood derived from patients with autoimmune hepatitis or chronic hepatitis C with autoimmune phenomena.
Ogawa S; Sakaguchi K; Takaki A; Shiraga K; Sawayama T; Mouri H; Miyashita M; Koide N; Tsuji T
J Gastroenterol Hepatol; 2000 Jan; 15(1):69-75. PubMed ID: 10719750
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive approach to indicate risk factors of nonalcoholic steatohepatitis overlapping autoimmune hepatitis based on peripheral lymphocyte pattern.
Kado A; Tsutsumi T; Yotsuyanagi H; Ikeuchi K; Okushin K; Moriya K; Koike K; Fujishiro M
J Gastroenterol; 2023 Dec; 58(12):1237-1251. PubMed ID: 37707595
[TBL] [Abstract][Full Text] [Related]
19. In-situ immunophenotyping study of hepatic-infiltrating cytotoxic cells in chronic active hepatitis C.
Fiore G; Angarano I; Caccetta L; Serrone M; Jirillo E; Schiraldi O; Antonaci S
Eur J Gastroenterol Hepatol; 1997 May; 9(5):491-6. PubMed ID: 9187883
[TBL] [Abstract][Full Text] [Related]
20. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.
Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; Jiménez P; Garrido F; Anderson P; Ruiz-Cabello F; López-Ruz MÁ
Front Immunol; 2020; 11():596553. PubMed ID: 33324414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
